CPAY vs SKWD: which is the better buy in 2026?
On Alexandria's Compass, Corpay, Inc. has the edge with a 92/100 score versus 90/100 for SKWD. Here is how they stack up, factor by factor.
Corpay, Inc.
NYSE:CPAY
B2B payments compounder trading at 11.5x forward earnings while growing 25% and printing $2.1B free cash, the market still treats it like a gas card company.
Full CPAY analysisSkyward Specialty Insurance Group, Inc.
NASDAQ:SKWD
Specialty P&C underwriter compounding book value at 17% ROE, trading at 2.2x book while the soft market hasn't actually arrived in their niches.
Full SKWD analysisFactor by factor
Get head-to-heads like this, free
Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is CPAY or SKWD the better buy in 2026?
By Compass Score, Corpay, Inc. (NYSE:CPAY) edges it at 92/100 versus 90/100 for SKWD. Both scores update weekly and reflect a contrarian, forward-looking read, not a recommendation.
How does Alexandria compare CPAY and SKWD?
Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.
Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.